|
Prevention of Arthritis-Related Work Disability Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Prevention of Arthritis-Related Work Disability conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Prevention of Arthritis-Related Work Disability Clinical research trials and Prevention of Arthritis-Related Work Disability healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Prevention of Arthritis-Related Work Disability. Prevention of Arthritis-Related Work Disability Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Prevention of Arthritis-Related Work Disability clinical trial. Subjects frequently obtain the most expert healthcare possible for their Prevention of Arthritis-Related Work Disability condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Prevention of Arthritis-Related Work Disability  Prevention of Arthritis-Related Work Disability
Prevention of Arthritis-Related Work Disability
For Condition: Rheumatoid Arthritis,Systemic Lupus Erythematosus,Osteoarthritis, Knee,Ankylosing Spondylitis
Status: Completed
Sponsor(s): National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) ,
Synopsis: People with rheumatic disorders (arthritis) often have trouble keeping their jobs. This study will look at whether vocational rehabilitation (VR) will improve the ability of employed people with arthritis to keep their jobs. Job retention VR services target key factors that increase the risk of job loss. They aim to modify jobs to reduce barriers caused by functional limitations and disease symptoms, future career planning, and establish a partnership with a VR counselor for ongoing help. We will conduct the study among patients with rheumatic disorders recruited in eastern Massachusetts. We will give 120 study participants job retention services provided by VR counselors. We will give another 120 participants literature about employment- related resources. We will compare the outcomes of the two groups to evaluate the usefulness of job retention services in preventing job loss in people with rheumatic disorders.
Details: Job loss commonly occurs among people with rheumatic disorders. This study will determine whether vocational rehabilitation (VR) provided to employed people with rheumatic disorders will improve their ability to remain employed. VR is applied primarily to people who have already lost their jobs. However, using job retention VR services may prevent, or delay, the onset of employment work loss among people with rheumatic disorders. Job retention VR services target important employment-loss risk factors. They do so by modifying jobs to reduce barriers posed by functional limitations and symptoms, promoting future career planning, and establishing an alliance with a VR counselor for ongoing assistance. The study is a randomized, controlled trial conducted among patients with rheumatic disorders recruited from the practices of rheumatologists in eastern Massachusetts. We will randomly assign 120 study participants to receive job-retention services provided by VR counselors and 120 participants (controls) to receive literature about employment-related resources. We will assess intermediate outcome variables (self-efficacy, work limitations, and job accommodation-seeking behaviors) and the endpoint outcome variable, work instability (a measure that includes employment loss), immediately prior to the interventions and at 6-month intervals over a 24-month period after the interventions are carried out. We will compare the outcomes of the two groups to evaluate the usefulness of job retention services in forestalling work instability in this population.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Must currently be employed full or part time - Must live in selected communities in eastern Massachusetts Exclusion Criteria: - Plans to move from area - Plans to have joint replacement surgery in next 6 months - Plans to retire or go on disability within next 2 years
Total Enrollment: 240
Location and Contact Information:
Overall Study Official:
SaralynnAllaire, Principal Investigator, Boston University School of Medicine
Boston University School of Medicine
Boston, Massachusetts, 02118
United States
Additional Information:
Study ID Numbers: NIAMS-012; P60 AR20613,EEHRS Project 3
Study Start Date: September 1997
Record last reviewed: July 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000416
Other Rheumatoid Arthritis Studies:
1. Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
2. Phase I Study of High-Dose Cyclophosphamide, Anti-Thymocyte Globulin, and Total Body Irradiation With T-Cell-Depleted Autologous Bone Marrow Rescue in Patients With High-Risk Rheumatoid Arthritis
3. 3 Different Dose Levels Of CCI-779 In Subjects With Active Rheumatoid Arthritis On Concomitant Methotrexate Therapy
4. Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients with Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate
5. Genetic Registry for Rheumatoid Arthritis
Related Studies:
Other Rheumatoid Arthritis Clinical Trials
Other Massachusetts Clinical Trials
Other Boston Clinical Trials
Prevention of Arthritis-Related Work Disability
|
|
|
|
|
|
|
|
